Clinical Trials News for PV and ET Patients

Last week two companies reported news on their clinical trials for myeloproliferative neoplasms:

  • AOP Orphan Pharmaceuticals announced that Phase III trials were going well for their study on Pegasys in PV patients. This study is being conducted in Europe and is currently recruiting.
  • Promedior has initiated a new Phase II clinical trial for their compound, PRM-151, in people with myelofibrosis.

Ongoing clinical trials for PV, ET, and MF can be found at as well as the MPN Research Foundation's site. Participating in a clinical trial should be considered carefully and discussed with your physician and family. 

Author: Michelle Woehrle

Michelle Woehrle joined the MPN Research Foundation in 2007 after being inspired by their mission to fund research that will improve the lives of people living with the rare blood cancers PV, ET and MF. In 2015 she was promoted to Executive Director. She has assisted with the expansion of the grants program, grassroots initiatives to connect with more patients internationally and optimize operations for the Foundation.

About the Blog

Check back regularly for updates about what’s happening in the MPN community, from advocacy to research..



Get free, timely information on living with an MPN.